Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human. - Wikidata - awgldk - TriplyDB

Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.

Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.

http://www.wikidata.org/entity/Q35825816

about

Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels Stiripentol Stiripentol : in severe myoclonic epilepsy of infancy (dravet syndrome).Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the Internati The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4.A screening study of drug-drug interactions in cerivastatin users: an adverse effect of clopidogrel Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN.Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs.Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions.Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children.Stiripentol in the Management of Epilepsy.Comparative evaluation of humic substances in oral drug delivery.Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis.

P2860

Q28237504-8CFCA5A3-0367-418D-9616-23322E694A3E Q28261980-80AE1EC0-6E7D-4767-A544-196BD3B15699 Q34302354-49812F45-2E23-4F2B-877A-55B8F11AA2D6 Q36304546-E4E4D854-E33F-41B7-A0A3-21448D4DAA08 Q37308650-8BD50A5D-7863-4D14-A7F0-7610B0EA62F3 Q37316562-C1C177CF-0189-4AF1-8F0A-18933B5F162E Q37973439-6630053A-23D4-45A0-B543-1CF373A98229 Q38115721-822EEC02-18D3-4127-97B3-A207E7103B82 Q38684505-08733D31-1A36-42E8-9E02-30832AD9B6F3 Q39074126-E491DE07-3CBE-4C54-BF0C-F20FD659D108 Q39256887-5D728F14-02C8-43F9-89A1-F46E2BE4A4B6 Q42085824-3F21C5E1-00F3-483C-A92A-BBF8D26CF837 Q48364123-CE84E172-B7DA-44E2-866A-67AA54D35123

P2860

Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.

http://www.wikidata.org/entity/Q35825816

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.

@ast

Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.

@en

type

label

Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.

@ast

Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.

@en

prefLabel

Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.

@ast

Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.

@en

P1433

Q35825816-1E560DF2-B064-41FC-A3A9-05A1DEB1BA6A

P1476

Q35825816-976DDC8B-3479-4267-84BE-EC14FE8C3F8D

P2093

Q35825816-19178ADE-DF4A-4EB3-AE85-A88259C072C8

Q35825816-25167F34-231E-4BB2-8A70-F99E90E13652

Q35825816-293B7BEC-EA89-410A-A2E1-4AE4589C7289

Q35825816-628839D9-8A78-47F8-8F07-03FE6390B021

Q35825816-BA74EB2D-54A1-4F0B-93AC-5B0E61726F4F

Q35825816-DDCC6F35-E6F8-4E09-8240-D27DE874B3CF

Q35825816-FB2DC124-FFB2-4BBD-977E-9016EAD560B1

P2860

Q35825816-066127C2-168C-411C-88F1-9073C993E8FF

Q35825816-0EA96DA7-98F4-401D-8C70-A763F6526EED

Q35825816-1DD2ADF5-9E13-4A7D-99E2-7BAEDBC4878B

Q35825816-2A10AD47-D7F4-452E-BA55-0436CECF8421

Q35825816-40EAAADB-E1F6-40DC-AD1B-9573B9F97CBF

Q35825816-7EAD1A2A-C9B0-4E65-A3F9-1ADF5A67F98C

Q35825816-83BD33DE-213C-45E5-A26F-330744A9F28D

Q35825816-AE640F4F-4284-4262-8985-DD0B62EDF82C

Q35825816-E6344459-9E5A-4F81-96F5-B20854F28397

Q35825816-F93AC7B5-8F20-4269-ABC3-C44564E92A14

P304

Q35825816-E0C01B19-D51C-4FCC-97F8-5C4E13304146

P31

Q35825816-92B050A4-01AB-472E-9C2B-B4CCA7467DC2

P356

Q35825816-42B08F7E-36F6-4F89-8AC5-2EEAE75B4BD7

P407

Q35825816-DAC05C3C-893A-465D-8516-78CBFDCE917D

P433

Q35825816-F1C96266-C626-4527-B6B7-39590D9B75D3

P478

Q35825816-BA2A287E-754D-4930-A537-3E6A9F071F5C

P577

Q35825816-AFC05627-706B-409B-81D0-1001C0119872

P5875

Q35825816-899EE97A-D686-4659-BE6E-9077C63B2BBF

P698

Q35825816-D4D4A8E4-3097-4472-9466-ED911438103D

P932

Q35825816-12DF8C40-747C-4C9D-8BB3-332240555C9E

P356

J.0306-5251.2003.01919.X

P1433

British Journal of Clinical Pharmacology

P1476

Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.

@en

P2093

A Tran

http://www.w3.org/2001/XMLSchema#string

E Rey

http://www.w3.org/2001/XMLSchema#string

G Pons

http://www.w3.org/2001/XMLSchema#string

J M Treluyer

http://www.w3.org/2001/XMLSchema#string

J Vincent

http://www.w3.org/2001/XMLSchema#string

N Cazali

http://www.w3.org/2001/XMLSchema#string

P d'Athis

http://www.w3.org/2001/XMLSchema#string

P2860

Stiripentol: efficacy and tolerability in children with epilepsy

Effect of stiripentol on carbamazepine plasma concentration and metabolism in epileptic children

Protective effect of stiripentol on acetaminophen-induced hepatotoxicity in rat.

Effect of microsomal preparations and induction on cytochrome P-450-dependent monooxygenases in fetal and neonatal rat liver.

Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450.

Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism.

An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation.

Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2.

Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir.

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

P304

526-536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.0306-5251.2003.01919.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8979161

http://www.w3.org/2001/XMLSchema#string

P698

14651727

http://www.w3.org/2001/XMLSchema#string

P932

1884392

http://www.w3.org/2001/XMLSchema#string